Probiotics in inflammatory bowel disease—therapeutic rationale and role
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 56 (6) , 809-818
- https://doi.org/10.1016/j.addr.2003.11.003
Abstract
No abstract availableKeywords
Funding Information
- European Commission (PROGID QLK-2000-00563)
- Higher Education Authority
- Health Research Board
- Science Foundation Ireland
This publication has 58 references indexed in Scilit:
- PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissectionGut, 2002
- Crohn's diseaseThe Lancet, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Toll Meets Bacterial CpG-DNAImmunity, 2001
- Toll of allergy reduced by probioticsThe Lancet, 2001
- Lactic acid bacteria: the bugs of the new millenniumCurrent Opinion in Microbiology, 2000
- Salmonella typhimurium induces epithelial IL-8 expression via Ca2+-mediated activation of the NF-κB pathwayJournal of Clinical Investigation, 2000
- Immunity and probioticsImmunology Today, 1999
- TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORAThe Lancet, 1989
- Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.Gut, 1988